Skip to main content

MEBEVERINE GPPL, MEBEVERINE GXP, CMEBEVERINE, COLOBEVERINE, COLOVERINE, CVERINE, MEBERINE (Generic Partners Pty Ltd)

Product name
MEBEVERINE GPPL, MEBEVERINE GXP, CMEBEVERINE, COLOBEVERINE, COLOVERINE, CVERINE, MEBERINE
Date registered
Evaluation commenced
Decision date
Approval time
167 working days (255)
Active ingredients
Mebeverine hydrochloride
Registration type
New generic medicine
Indication
MEBEVERINE GPPL, MEBEVERINE GXP, CMEBEVERINE, COLOBEVERINE, COLOVERINE, CVERINE, MEBERINE (tablets) is indicated in the management of the irritable bowel syndrome ('irritable colon', 'spastic colon', functional bowel disorders', spastic constipation', 'nervous diarrhoea'). Mebeverine hydrochloride is used to treat the symptoms of this condition - i.e. abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence.

Help us improve the Therapeutic Goods Administration site